Physician profile
Keith M Lipsmeyer
NPI 1528055738
$704.99
in general payments reported to CMS, 2019-2025
17 companies · $63.88 in 2025
The $63.88 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.38 · 2020: $118 · 2021: $217 · 2022: $49.49 · 2023: $109 · 2024: $96.28 · 2025: $63.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $96.15 | 2020-2023 | Wegovy |
| Glaxosmithkline, LLC. | $94.97 | 2021-2025 | Trelegy Ellipta |
| Pfizer INC. | $84.09 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $77.77 | 2020-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $74.33 | 2023-2024 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.18 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $39.48 | 2021 | |
| Alkermes, INC. | $32.97 | 2022 | |
| Abbvie INC. | $30.63 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $26.18 | 2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $16.52 | 2022 | |
| Amgen INC. | $15.92 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.21 | 2023 | Xifaxan, Trulance |
| Mylan Specialty L.P. | $13.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.81 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.34 | 2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Lipsmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.